Completed
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
NCT00363142
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site Fountain Valley, California, United States